Page 5 - Sciences Ltd News Today

Roivant Sciences Investors Score Big Today

Immunovant (NASDAQ:IMVT – Free Report) had its price target hoisted by Cantor Fitzgerald from $30.00 to $45.00 in a report issued on Monday, Benzinga reports. They currently have an overweight rating on the stock. A number of other research analysts have also commented on the stock. UBS Group upgraded shares of Immunovant from a neutral […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 153,027 shares of the company’s stock in a transaction dated Thursday, October 5th. The shares were sold at an average price of $10.11, for a total value of $1,547,102.97. Following the completion of the transaction, the chief operating officer now owns 595,397 shares […]

Acumen Research and Consulting recently published report titled “Human Growth Hormone Market Forecast, 2023 - 2032”...

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 500,000 shares of the firm’s stock in a transaction dated Wednesday, September 27th. The shares were sold at an average price of $13.02, for a total transaction of $6,510,000.00. Following the completion of the sale, the chief operating officer now owns 595,397 shares […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) was the recipient of some unusual options trading activity on Thursday. Investors purchased 2,964 call options on the company. This represents an increase of approximately 82% compared to the typical volume of 1,625 call options. Insider Activity at Roivant Sciences In related news, COO Eric Venker sold […]

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $10.21, but opened at $11.80. Roivant Sciences shares last traded at $12.21, with a volume of 4,771,961 shares traded. Analyst Ratings Changes A number of research firms recently issued reports […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) CAO Rakhi Kumar sold 1,724 shares of the business’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $12.00, for a total transaction of $20,688.00. Following the transaction, the chief accounting officer now owns 197,950 shares in the company, […]

Roivant Sciences (NASDAQ:ROIV – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.10), Briefing.com reports. The firm had revenue of $21.60 million for the quarter, compared to analyst estimates of $24.49 million. Roivant Sciences had […]